Elevance Health (ELV) FY2022 results: revenue $156.6 billion, up 13.0% on the year
Elevance Health, Inc. (ELV) reported revenue of $156.6 billion for fiscal 2022, the year ended 31 December 2022, up 13.0% on the year before. Net income was $5.9 billion, down 4.3%, and diluted earnings per share $24.28. The figures are the company's own, from the 10-K it filed with the SEC on 15 February 2023.
Revenue
$156.6 billion
+13.0% on the year
FY2015FY2022
Operating margin
5.3%
5.5% a year earlier
FY2015FY2022
Net income
$5.9 billion
-4.3% on the year
FY2015FY2022
Diluted EPS
$24.28
-2.7% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
8,399
8,364
10,688
+0.4%
Capital expenditure
1,152
1,087
1,021
+6.0%
Free cash flow
7,247
7,277
9,667
-0.4%
Free cash flow margin
4.6%
5.2%
7.9%
Cash from investing
-4,560
-9,638
-7,324
Cash from financing
-1,318
423
-2,567
Depreciation and amortisation
1,675
1,302
1,154
+28.6%
Share-based compensation
264
255
283
+3.5%
Buybacks
2,316
1,900
2,700
+21.9%
Dividends paid
1,229
1,104
954
+11.3%
Dividend per share
$5.12
$4.52
$3.80
+13.3%
Diluted shares, weighted
243m
247m
254m
-1.6%
Shares outstanding at period end
238m
242m
245m
-1.6%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
36,307
36,060
33,199
+0.7%
Non-controlling interest
87.0
68.0
0.0
+27.9%
Short-term borrowings
n/a
n/a
0.0
Debt
24,114
23,031
20,035
+4.7%
Operating lease liabilities
751
864
n/a
-13.1%
Other liabilities
41,513
37,437
33,381
+10.9%
Total liabilities and equity
102,772
97,460
86,615
+5.5%
Fixed assets
4,316
3,919
3,483
+10.1%
Goodwill
24,383
24,228
21,691
+0.6%
Intangible assets
10,315
10,615
9,405
-2.8%
Investments
26,704
26,899
23,995
-0.7%
Cash and equivalents
7,387
4,880
5,741
+51.4%
Other assets
29,667
26,919
22,300
+10.2%
Total assets
102,772
97,460
86,615
+5.5%
10-K for the year ended 31 December 2022, filed 15 February 2023: the filing.